Andrew Lloyd graduated from Robinson College, University of Cambridge in 1986 with a degree in Natural Sciences, specialising in bioorganic chemistry, biochemistry and pharmacology. He completed his PhD in biopharmaceutics and was appointed to the academic staff in the Department of Pharmacy, University of Brighton as a Lecturer in Pharmaceutical Sciences in 1989, and was promoted to Senior Lecturer in 1993. He was made Reader in Biopharmaceutical Sciences and elected to Fellowship of the Royal Society of Chemistry in 1998 and promoted to the chair in Biomedical Materials in 2000. He was appointed as Joint Head of Research with responsibility for strategic planning in the School of Pharmacy & Biomolecular Sciences in 2000, Dean of the Faculty of Science & Engineering in 2003 and Dean of the College of Life, Health & Physical Sciences in 2014. Following a 6 month period as interim Pro-Vice-Chancellor (Reserach & Enterprise) in 2016, Andrew was appointed to his present role as Associate Pro-Vice-Chancellor (Academic Operations) in July 2017.
Andrew was awarded the University of Brighton Patani Gold Medal for Pharmaceutical Research in 1990, the University of Brighton Chairman’s Award for Innovation in 1996 and 2005, the Lilly Prize for Pharmaceutical Excellence in 1999, the Royal Pharmaceutical Society of Great Britain's (RPSGB) Conference Science Award in 2000, the United Kingdom Society for Biomaterials (UKSB) Biocompatibles’ Endowed Lectureship in 2005. Professor Lloyd was the British Pharmaceutical Conference Science Chair in 2008.
Andrew's research interests include the development and evaluation of novel materials for drug delivery and medical device applications, microbial models of drug metabolism and pharmaceutical processing. At present his research focuses on the development of novel medical materials which offer improved performance in the body in order to reduce the costs of primary healthcare. The research has been funded by EPSRC, BBSRC, NHS, Royal Society, European Union and various international pharmaceutical and medical device companies.
He has published over 300 articles and was formerly Consultant Editor for 'Drug Discovery Today' and 'Pharmaceutical Science & Technology Today' and co-edited of the undergraduate textbook ‘Drug Delivery & Targeting for Pharmacists and Pharmaceutical Scientists’. Professor Lloyd formerly served as a Member of the Council for the UK Society for Biomaterials, Member of the Institute of Materials, Mining and Mineralogy Biomedical Division Biomaterials Committee, Member of the RSC Biomaterials Chemistry Group Committee and is presently a member of the EPSRC Peer-review Council. He also serves on the editorial boards of Journal of Applied Biomaterials and Biomechanics (JABB) and Expert Review of Medical Devices.
Professor Lloyd acts in an advisory capacity for a number of pharmaceutical and medical device companies and was formerly a director of a small biotechnology company 'Cellective Ltd', which undertook contract research related to in vitro drug adsorption and the assessment of the biological compatibility of biomedical material.
Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods
European Journal of Pharmaceutical Sciences (2019) 136
Towards a synthetic osteo-odonto-keratoprosthesis.